top of page

Fenbendazole

The Joe Tippens Protocol

Listen to Joe Tippens' story:

For Joes full story please read his blog below. Once you have completed it, you will be given a password to gain access to the official facebook group.

Joe Tippens.png

Joe's protocol has now been updated. the contents of his original protocol can be found here:

https://i2b.us/fenbendazole-from-md-anderson-to-joe-tippens/

The new protocol, can be found here, but it's much more expensive: https://mycancerstory.rocks/81-2/

Joe's official facebook group is: https://www.facebook.com/groups/244815949755622

This is an excellent community of people consisiting of cancer sufferers and care givers, sharing their stories and progress. It is an excellent resource. The search function in the group is particularly helpful looking for cases involving a specific diagnosis. There are 48,500 members of this community. On the files tab of this page there are some excellent PDFs to download and digest.

Human patients are given fenbendazole as a therapy for cancer: https://baltimorepostexaminer.com/human-patients-are-given-fenbendazole-as-a-therapy-for-cancer/2022/10/15?fbclid=IwAR1WnrJJ6rEsecG8mIVLyc-BbkeFunO2owl0YhJHO5I0fclpdmci67sUxg0

Other fenbendazole related groups include:

Fenbendazole Protocol - Cancer Support Community with 34,500 members : https://www.facebook.com/groups/216675095063389 &

Fenbendazole, DCA - Cancer Support Community with 61,500 members: https://www.facebook.com/groups/1752645665108602

Be mindful as these groups have some people advocating much higher doses the Joe recommends. If you are looking to take fenbenzadole there are oncologists who can support you through your treatment at Heal Navigator. You can also see testimonials of others who have used fenbenzadole successfully.

Fenben Success Heal Navigator.png

Fenbenzadole Studies:

Fenbendazole acts as a moderate microtubule destabilizing agent and causes cancer cell death by modulating multiple cellular pathways

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6085345/

 

Unexpected Antitumorigenic Effect of Fenbendazole when Combined with Supplementary Vitamins https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2687140/

 

Veterinary Antiparasitic to Human Anticancer

https://encyclopedia.pub/entry/22484

Fenbendazole acts as a moderate microtubule destabilizing agent and causes cancer cell death by modulating multiple cellular pathways

https://www.nature.com/articles/s41598-018-30158-6

 

Anti-cancer effects of fenbendazole on 5-fluorouracil-resistant colorectal cancer cells

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437363/

 

An Update on the Biologic Effects of Fenbendazole - 5 Studies https://www.ingentaconnect.com/content/aalas/cm/2022/00000072/00000004/art00001

 

The Antitumor Potentials of Benzimidazole Anthelmintics as Repurposing Drugs

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458798/

 

Fenbendazole as a Potential Anticancer Drug

https://ar.iiarjournals.org/content/33/2/355.short & https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580766/

 

Progress in Redirecting Antiparasitic Drugs for Cancer Treatment

https://www.tandfonline.com/doi/full/10.2147/DDDT.S308973

 

Fenbendazole Suppresses Growth and Induces Apoptosis of Actively Growing H4IIE Hepatocellular Carcinoma Cells via p21-Mediated Cell-Cycle Arrest

https://www.jstage.jst.go.jp/article/bpb/45/2/45_b21-00697/_article/-char/ja/

 

The Antitumor Potentials of Benzimidazole Anthelmintics as Repurposing Drugs

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458798/

 

Involvement of reactive oxygen species in the anti-cancer activity of fenbendazole, a benzimidazole anthelmintic https://www.kjvr.org/journal/view.php?doi=10.14405/kjvr.2020.60.2.79

 

Fenbendazole Enhancing Anti-Tumor Effect: A Case Series

https://www.scitechnol.com/peer-review/fenbendazole-enhancing-antitumor-effect-a-case-series-2Kms.php?article_id=14307&fbclid=IwAR1MIwI6WsbWxY5m69dNeL-9cky_mSKzsPSzyXQB3nKB6ibiiVdsP18qmWA

 

Double Repositioning: Veterinary Antiparasitic to Human Anticancer

https://www.mdpi.com/1422-0067/23/8/4315

 

Repositioning of Anthelmintic Drugs for the Treatment of Cancers of the Digestive System

https://www.mdpi.com/1422-0067/21/14/4957

bottom of page